Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • dbroh11
    Junior Member
    • Jan 2014
    • 8

    RNA-Seq Experimental Design Questions

    Hello,

    My name is David Brohawn and I am new to RNA-Seq.

    My advisor and I are interested in doing an RNA-Seq experiment to compare the transcriptomes of iPSC neurons we generate from both ALS patients and controls. Ultimately we would like to identify molecular phenotypes based on transcriptome expression profiles for different instances of ALS (much like how cancer researchers now identify underlying molecular phenotypes for different instances of a given cancer).

    We are primarily interested in generating transcriptome profiles (involving both coding and non-coding RNA and novel transcripts), with a heavy interest in differential gene expression and less interest in mapping full transcript isoforms.

    As I understand it, a greater number of small reads is best to assess differential gene expression (Solid and Illumina look most amenable to this), while a smaller number of long reads is best to assess isoforms (Roche and PacBio look most amenable to this).

    I see the ENCODE project recommends “Experiments whose purpose is discovery of novel transcribed elements and strong quantification of known transcript isoforms… a minimum depth of 100-200 M 2 x 76 bp or longer reads is currently recommended.”

    We plan on using Illumina Truseq total RNA prep kits followed by sequencing on the Illumina HiSeq 2500. An Illumina rep quoted 187 million reads per lane as typical output for a 2X100 run. If this is true, I am thinking we multiplex our 20 total samples (10 cases and controls) and run 11 total lanes which would average out to just over 100 million reads per sample.

    We would then analyze the data with the Tuxedo Suite bioinformatics package (we may substitute STAR for Tophat and Bowtie), and visualize our data using CummeRbund.

    We are considering purchasing a LINUX based machine or a Mac with these specs for processing:

    CPU – 2 quad core processors
    HDD 8 TB – RAID assembly of 4 2-TB drives
    RAM – 24 GB of RAM
    GHz – 3.2 GHz

    I have been told the number of reads per sample may be overkill given our goals, but I am really following ENCODEs recommendations. Do you all have any suggestions based on what I have reported?

    Thanks for taking the time to read and respond!

    Dave Brohawn
  • GenoMax
    Senior Member
    • Feb 2008
    • 7142

    #2
    Have a look at this paper: http://seqanswers.com/forums/showthread.php?t=40365

    Comment

    • TonyBrooks
      Senior Member
      • Jun 2009
      • 303

      #3
      Some comments and analysis from the exciting and fast moving world of Genomics. This blog focuses on next-generation sequencing and microarray technologies, although it is likely to go off on tangents from time-to-time


      You could run all 20 of your samples across 2 lanes and get somewhere approaching 20m reads per sample. This should be more than adequate for differential expression analysis.

      Comment

      • dbroh11
        Junior Member
        • Jan 2014
        • 8

        #4
        Hey Guys,

        It looks like for a run of the mill differential gene expression analysis, 20-30 M reads is more than sufficient based on your response, Tony, and the paper that GenoMax kindly supplied.

        While we are most interested in differential gene expression, we still want to have a thorough representation of the transcriptome for both control and disease groups including novel transcripts. We aren't overly concerned with the ability to capture transcripts expressed at very low levels. Does 20-30 M still sound like a safe bet given these additional points?

        Further, while I understand the use of short reads is more amenable to differential gene expression analysis than it is for isoform detection or mapping, I would like to optimize our short read study design in a way that most benefits the Tuxedo Suite software algorithms in probabilistically guessing what isoforms we have present. This led me to choose the Illumina platform over Solid (100 bp reads over 35 bp reads), and paired end instead of single end reads to aid in alignment efforts. Does my rationale and this aspect of the study design sound appropriate for my goal?

        I appreciate your helping a newbie

        Dave

        Comment

        • GenoMax
          Senior Member
          • Feb 2008
          • 7142

          #5
          Originally posted by TonyBrooks View Post
          http://core-genomics.blogspot.co.uk/...ions-need.html

          You could run all 20 of your samples across 2 lanes and get somewhere approaching 20m reads per sample. This should be more than adequate for differential expression analysis.
          @Tony: Can you correct this URL? It does not seem to be pointing to a specific link.
          Last edited by GenoMax; 01-31-2014, 01:01 PM.

          Comment

          • GenoMax
            Senior Member
            • Feb 2008
            • 7142

            #6
            Originally posted by dbroh11 View Post
            This led me to choose the Illumina platform over Solid (100 bp reads over 35 bp reads), and paired end instead of single end reads to aid in alignment efforts. Does my rationale and this aspect of the study design sound appropriate for my goal?

            I appreciate your helping a newbie

            Dave
            Sequencing more reads is not going to hurt but what the general consensus is that you do not want to go overboard (i.e. 100 million) since that is a case of diminishing returns.

            There has been past discussion on benefits of single-end and paired-end reads but nothing that is of recent vintage. Here are a couple of links to peruse.

            Discussion of next-gen sequencing related bioinformatics: resources, algorithms, open source efforts, etc

            Discussion of next-gen sequencing related bioinformatics: resources, algorithms, open source efforts, etc

            Comment

            • westerman
              Rick Westerman
              • Jun 2008
              • 1104

              #7
              Our sequencing center most often aims for 30M reads per sample for rnaSeq projects. However balancing the samples to get 30M each is troublesome. The way we do this is to do one (partial) sequencing run that undershoots 30M and then re-cluster the samples so that the next run will combined with the first run in order to bring up the per-sample reads to 30M. If you were going to do a 'one-shot' sequencing run then you will have to aim for around 50M reads in order to have at least 25M reads per sample. I'll agree that aiming for 100M reads is overkill.

              Comment

              • dbroh11
                Junior Member
                • Jan 2014
                • 8

                #8
                I appreciate your guys help with this - Do you have literature aside from the paper GenoMax sent that supports using far less than 100M reads (what Encode proposed?) I understand ENCODE is not the end all be all and their recommendations are several years old, but would like to better understand rationale/see more empirical data suggesting 50M is sufficient prior to committing funds to the project.

                In addition, do you all know of any literature out there showing the use of 100 bp reads over 35 bp reads (Illumina vs SOLiD) truly benefits Cufflink's estimation of the prevalence of different isoforms? We are most interested in differential gene expression so I have narrowed our design down to using shorter reads, but am still mulling over the pros and cons of these two platforms.

                Many thanks

                Dave

                Comment

                • gringer
                  David Eccles (gringer)
                  • May 2011
                  • 845

                  #9
                  If you want the best isoform detection capability and have lots of money, long paired-end reads on illumina are the best option. Note that with 250bp reads and a 400bp fragment length, you should be able to get 400bp of continuous sequencing for most reads, with overlap (for consistency checks) around 50bp. We've found that 30Mish reads (i.e. 10M~100M) are fine for hypothesis-generating analysis, so go ahead and multiplex if you've got more than that.

                  The longer the sequence, the more chance you have of catching multiple splice points in a single read. If you don't do this you have to guess at possible isoforms based on frequency counts.
                  Last edited by gringer; 02-03-2014, 12:46 PM.

                  Comment

                  • AllSeq
                    Registered Vendor
                    • Oct 2013
                    • 138

                    #10
                    Originally posted by gringer View Post
                    If you want the best isoform detection capability and have lots of money, long paired-end reads on illumina are the best option.
                    If you want the best isoform detection capability and have an INSANE amount of money, PacBio runs with a few different size selections would be the best option.
                    AllSeq - The Sequencing Marketplace
                    [email protected]
                    www.AllSeq.com

                    Comment

                    • mukeshwar
                      Junior Member
                      • Apr 2013
                      • 4

                      #11
                      Hi,

                      I am using TruSeq RNA sample prep kit v2 for WTA library. I started with the 6 ug of total RNA followed by Elute-prime fragment for 2 mins, 1st strand cDNA and then 2nd strand cDNA synthesis and got the following qubit readings

                      Elute primer fragment (RNA BR Assay): 15.6 ng/ul
                      dsCDNA synthesis (DNA dsHS assay)_before 1.8x bead purification: 0.312 ng/ul
                      dsCDNA synthesis (DNA dsHS assay)_after 1.8x bead purification: 0.225 ng/ul

                      On the basis of qubit reading i wanted to know that

                      >is it enough concentration of dscDNA or i am loosing the dscDNA amount? i didn't check the dscDNA profile on HS chip.
                      > My mRNA enrichment process and the results are satisfactory for cDNA conversion ?
                      > Is cDNA conversion done?
                      > How can i check my first strand cDNA product?

                      Basically, i wanted to know the checkpoints of each step to confirm that library preparation protocol is running correctly?
                      Last edited by mukeshwar; 02-04-2014, 10:21 AM.

                      Comment

                      • GenoMax
                        Senior Member
                        • Feb 2008
                        • 7142

                        #12
                        Originally posted by mukeshwar View Post
                        Hi,

                        I am using TruSeq RNA sample prep kit v2 for WTA library. I started with the 6 ug of total RNA followed by Elute-prime fragment for 2 mins, 1st strand cDNA and then 2nd strand cDNA synthesis and got the following qubit readings

                        Elute primer fragment (RNA BR Assay): 15.6 ng/ul
                        dsCDNA synthesis (DNA dsHS assay)_before 1.8x bead purification: 0.312 ng/ul
                        dsCDNA synthesis (DNA dsHS assay)_after 1.8x bead purification: 0.225 ng/ul

                        On the basis of qubit reading i wanted to know that

                        >is it enough concentration of dscDNA or i am loosing the dscDNA amount? i didn't check the dscDNA profile on HS chip.
                        > My mRNA enrichment process and the results are satisfactory for cDNA conversion ?
                        > Is cDNA conversion done?
                        > How can i check my first strand cDNA product?

                        Basically, i wanted to know the checkpoints of each step to confirm that library preparation protocol is running correctly?
                        Please create a new thread since your question is unrelated to the thread you posted in.

                        New threads can be created by:

                        SeqAnswers.com --> Click "Forums" left navigation box --> Choose an appropriate forum to post question in --> "New Thread" button at top left.

                        You can then delete this post by choosing "Edit" --> "Go Advanced" --> Delete.

                        Comment

                        Latest Articles

                        Collapse

                        • SEQadmin2
                          Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
                          by SEQadmin2


                          Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

                          The systematic characterization of the human proteome has
                          ...
                          07-20-2026, 11:48 AM
                        • SEQadmin2
                          Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
                          by SEQadmin2



                          Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
                          ...
                          07-09-2026, 11:10 AM
                        • SEQadmin2
                          Cancer Drug Resistance: The Lingering Barrier to Rising Survival
                          by SEQadmin2



                          Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

                          There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
                          07-08-2026, 05:17 AM

                        ad_right_rmr

                        Collapse

                        News

                        Collapse

                        Topics Statistics Last Post
                        Started by SEQadmin2, 07-24-2026, 12:17 PM
                        0 responses
                        26 views
                        0 reactions
                        Last Post SEQadmin2  
                        Started by SEQadmin2, 07-23-2026, 11:41 AM
                        0 responses
                        21 views
                        0 reactions
                        Last Post SEQadmin2  
                        Started by SEQadmin2, 07-20-2026, 11:10 AM
                        0 responses
                        210 views
                        0 reactions
                        Last Post SEQadmin2  
                        Started by SEQadmin2, 07-13-2026, 10:26 AM
                        0 responses
                        78 views
                        0 reactions
                        Last Post SEQadmin2  
                        Working...